Galectin Therapeutics
GALT
#9131
Rank
A$0.13 B
Marketcap
$2.06
Share price
-7.04%
Change (1 day)
-60.95%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.99

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.03. In 2022 the company made an earnings per share (EPS) of -$1.02 a decrease over its 2021 EPS that were of -$0.81.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.99-2.66%
2022-$1.0225%
2021-$0.8130%
2020-$0.63-6.98%
2019-$0.6713.16%
2018-$0.59-22.45%
2017-$0.77-35.53%
2016-$1.19-13.64%
2015-$1.3811.39%
2014-$1.23-39.69%
2013-$2.0581.94%
2012-$1.13-32.08%
2011-$1.667.07%
2010-$1.55-17.5%
2009-$1.88150%
2008-$0.75-68%
2007-$2.34127.27%
2006-$1.03-52.17%
2005-$2.16-20.69%
2004-$2.7252.63%
2003-$1.78-13.64%
2002-$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$20.04 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.30-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA